|
| Tuesday, 10 January 2023, 11:00 HKT/SGT | |
| |  | |
Source: Avendus | |
|
|
|
SINGAPORE, Jan 10, 2023 - (ACN Newswire) - Avendus, one of India's leading institutional financial services companies, announced the appointment of Sumit Dayal as Independent Non-Executive Director in Singapore today. He will provide guidance and corporate governance oversight as a Board member to Avendus Capital Pte. Limited (Singapore).
 | | Sumit Dayal |
A seasoned banker with over 30 years of corporate and investment banking experience, spent 16 years as Managing Director and headed various business units of Standard Chartered Bank in Singapore and Hong Kong. He also spent over 13 years in multiple roles in Bank of America across client risk and client coverage based in India, Singapore, and Hong Kong in the past.
Commenting on the appointment, Gaurav Deepak, Co-founder and CEO, Avendus Capital said, "We are delighted that Sumit has decided to join Avendus Singapore. We're confident that his exceptional experience and advisory will be of immense value to the franchise as we focus on making Singapore a strong base to grow our institutional franchise in Investment Banking, Institutional Equities and Wealth Management."
Sumit Dayal, Independent Non-Executive Director, Avendus Capital Pte. Limited said, "I am delighted to join Avendus. It's an institution that has been built on very strong fundamentals and one that I have admired immensely. I am looking forward to working with the firm to further deepen its linkages in the APAC region."
About Avendus
Avendus Group is a leading financial services firm with presence in the areas of Investment Banking, Wealth Management, Credit Solutions and Asset Management. Established in 1999 in Mumbai, India, Avendus is today present in 10 cities across India, US, UK and Singapore. Avendus partners with the Indian entrepreneur ecosystem to provide differentiated solutions that enable clients to meet their strategic aspirations.
Avendus Capital, the investment banking arm, is consistently ranked among the top investment banks in the country on the back of its in-depth domain understanding and a best in the class track record of domestic and cross-border transactions. Avendus' wide range of clients is testimony to its ability to serve its corporates throughout their life cycle -- from growth stage funding to large-sized transactions and M&A advisory.
Avendus Capital Inc located in New York is an Avendus Group entity offering M&A and Private Equity syndication services to clients in the US.
Avendus Capital Pte Limited located in Singapore is an Avendus Group entity undertaking Fund Management business in Singapore.
For more information, please visit www.avendus.com.
Topic: Press release summary
Source: Avendus
Sectors: Daily Finance, HR, Funds & Equities, Banking & Insurance, PE, VC & Alternatives
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem 
June 12, 2025 08:00 HKT/SGT
|
|
|
HKTDC Design Gallery x STICKYLINE present: "Love HK" Exhibition
June 11, 2025 23:13 HKT/SGT
|
|
|
This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure
June 11, 2025 21:00 HKT/SGT
|
|
|
Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance
June 11, 2025 10:00 HKT/SGT
|
|
|
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
June 10, 2025 19:00 HKT/SGT
|
|
|
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Tuesday, June 10, 2025 6:47:00 PM
|
|
|
UK MOD Signs Protector Support Contract with GA-ASI
June 10, 2025 06:00 HKT/SGT
|
|
|
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
June 9, 2025 19:30 HKT/SGT
|
|
|
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
June 9, 2025 17:00 HKT/SGT
|
|
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
June 9, 2025 12:52 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
